Abstract
This study explored the alleviative effect of ginkgolide B on Parkinson's disease (PD) in rats. PD model was established in 20 rats, which were then randomly divided into model and treatment group, 10 rats in each group. Other 10 rats were selected as control group. The treatment group was treated with ginkgolide B for four weeks. After treatment, compared with model group, in treatment group the behavior test and learning and memory test indexes were improved, the substantia nigra superoxide dismutase and glutathione peroxidase levels were increased, the substantia nigra malondialdehyde and inflammatory factor levels were decreased, and the substantia nigra phosphorylated phosphatidylinositol-3 kinase (p-PI3K)/phosphatidylinositol-3 kinase (PI3K) and phosphorylated serine-threonine protein kinase (p-Akt)/serine-threonine protein kinase (Akt) ratios were increased (all p<0.05). Ginkgolide B can alleviate PD in rats. The action mechanisms may be related to its resisting oxidative stress and inflammatory response and activating PI3K/Akt signaling pathway.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call